Erratum to: PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment

被引：0

作者：

Dimitrios Mathios

Jacob Ruzevick

Christopher M. Jackson

Haiying Xu

Sagar R. Shah

Janis M. Taube

Peter C. Burger

Edward F. McCarthy

Alfredo Quinones-Hinojosa

Drew M. Pardoll

Michael Lim

机构：

[1] The Johns Hopkins University School of Medicine,Department of Neurosurgery

[2] The Johns Hopkins University School of Medicine,Department of Dermatology

[3] The Johns Hopkins University School of Medicine,Department of Biomedical Engineering

[4] The Johns Hopkins University School of Medicine,Department of Pathology

[5] The Johns Hopkins University School of Medicine,Department of Oncology

[6] The Johns Hopkins University School of Medicine,Department of Medicine

[7] Johns Hopkins Hospital,Department of Neurosurgery

来源：

Journal of Neuro-Oncology | 2016年 / 128卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：183 / 183

共 50 条

[41] Evaluation of PD-L1, PD-L2, PD-1 and cytotoxic immune response in oral lichen planus [J].

Costa, Nadia Lago ;

Goncalves, Julie Ane Maria ;

de Lima, Sara Lia Goncalves ;

de Arruda, Jose Alcides Almeida ;

Miranda, Ana Carolina Campos ;

Mesquita, Ricardo Alves ;

da Silveira, Ericka Janine Dantas ;

Batista, Aline Carvalho .

ORAL DISEASES, 2020, 26 (06) :1246-1254

[42] Relevance of host and tumor PD-L1 expression in PD-L1 and PD-1 blockade [J].

Lin, Heng ;

Wei, Shuang ;

Vatan, Linda ;

Kryczek, Ilona ;

Zou, Weiping .

JOURNAL OF IMMUNOLOGY, 2017, 198 (01)

[43] Eosinophils Upregulate PD-L1 and PD-L2 Expression to Enhance the Immunosuppressive Microenvironment in Multiple Myeloma [J].

Driscoll, James ;

Aslam, Irim ;

Malek, Ehsan .

BLOOD, 2017, 130

[44] TARGETING PD1/PD-L1/PD-L2 SIGNALING IN ENDOMETRIOSIS [J].

Mamillapalli, Ramanaiah ;

Golden, Adriana ;

Taylor, Hugh S. ;

Gawde, Nimisha .

FERTILITY AND STERILITY, 2023, 120 (04) :E307-E307

[45] Expression and prognostic value of PD-L1 and PD-L2 in ovarian cancer [J].

Xue, Chunyan ;

Zhu, Dawei ;

Chen, Lujun ;

Xu, Yun ;

Xu, Bin ;

Zhang, Dachuan ;

Jiang, Jingting .

TRANSLATIONAL CANCER RESEARCH, 2019, 8 (01) :111-119

[46] Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents [J].

H Yang ;

C Bueso-Ramos ;

C DiNardo ;

M R Estecio ;

M Davanlou ;

Q-R Geng ;

Z Fang ;

M Nguyen ;

S Pierce ;

Y Wei ;

S Parmar ;

J Cortes ;

H Kantarjian ;

G Garcia-Manero .

Leukemia, 2014, 28 :1280-1288

[47] Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents [J].

Yang, H. ;

Bueso-Ramos, C. ;

DiNardo, C. ;

Estecio, M. R. ;

Davanlou, M. ;

Geng, Q-R ;

Fang, Z. ;

Nguyen, M. ;

Pierce, S. ;

Wei, Y. ;

Parmar, S. ;

Cortes, J. ;

Kantarjian, H. ;

Garcia-Manero, G. .

LEUKEMIA, 2014, 28 (06) :1280-1288

[48] Currently Used Laboratory Methodologies for Assays Detecting PD-1, PD-L1, PD-L2 and Soluble PD-L1 in Patients with Metastatic Breast Cancer [J].

Jeong, Seri ;

Lee, Nuri ;

Park, Min-Jeong ;

Jeon, Kibum ;

Song, Wonkeun .

CANCERS, 2021, 13 (20)

[49] Robust Preanalytical Performance of Soluble PD-1, PD-L1 and PD-L2 Assessed by Sensitive ELISAs in Blood [J].

Krueger, Kimberly ;

Mayer, Zsuzsanna ;

Kottmaier, Marc ;

Gerckens, Miriam ;

Boeck, Stefan ;

Luppa, Peter ;

Holdenrieder, Stefan .

BIOMEDICINES, 2022, 10 (10)

[50] Expression of PD-L1 and PD-1 in Cutaneous Warts [J].

Yu, Wesley ;

Berger, Timothy ;

Laszik, G. Zoltan ;

North, Jeffrey ;

Cohen, Jarish .

LABORATORY INVESTIGATION, 2019, 99

← 1 2 3 4 5 →